Lawmakers and biomedical research advocates raised concerns about reported efforts to tighten political control over NIH grantmaking. United for Cures executive director Erica Sward warned that politicization of grant administration could stall ongoing clinical trials. The reports also describe prior administration actions affecting research funding, including terminations or freezes affecting more than 1,800 research grants and proposals tied to budget reductions and forward-funding structures for multi-year NIH grants. Advocates argued that major governance changes would undermine independent scientific peer review.